FDA Inspection
Micronisierungs-Kontor Oberrot GmbHMicronisierungs-Kontor Oberrot GmbH – FDA Inspection, Feb 5, 2020
Record Details
This FDA Inspection record concerns Micronisierungs-Kontor Oberrot GmbH, with an inspection on February 5, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 5, 2020
- Product Type
- Drugs
View Company Profile
ID · 1d403d24-d35a-457a-bb27-ed2af06ba3c2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1142115
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Micronisierungs-Kontor Oberrot GmbH
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 11, 2023 | Not classified | Office of Inspections and Investigations | |
| March 17, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Micronisierungs-Kontor Oberrot GmbH
- FDA Inspection 1276276 - 2023-01-11
- FDA Inspection 971540 - 2016-03-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.